Dr. Vinay Prasad is back at the FDA's Center for Biologics Evaluation and Research, raising eyebrows after being ousted amid political turmoil and criticism. His return ignites debates about drug approvals and public health leadership under the Trump administration.
Discover the intriguing story of Amy Gleason, the newly appointed acting administrator of DOGE with a background in health care technology and ties to the Trump administration. Learn about her work in the federal response to the coronavirus pandemic and advocacy for juvenile myositis patients.
